UIO-623

N/A

Report date: 2025/01/26 16:09:54

Base Information

Drug NameUIO-623

Drug Alias Nameoncolytic virus therapy (Unleash Immuno Oncolytics)camelid antibody-targeted oncolytic virus therapy expressing immunostimulant cytokines (Unleash Immuno Oncolytics)UIO-623

ClassificationBiologics > Oncolytic virus

Mechanisms of ActionCytokine receptors agonists

TargetsCytokine receptorsInterleukin 18 receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUnleash Immuno Oncolytics Inc

China Registration ClassN/A

Develop Information

Active CompaniesUnleash Immuno Oncolytics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A